[HTML][HTML] A common pathomechanism in GMAP-210–and LBR-related diseases

A Wehrle, TM Witkos, JC Schneider, A Hoppmann… - JCI insight, 2018 - ncbi.nlm.nih.gov
A Wehrle, TM Witkos, JC Schneider, A Hoppmann, S Behringer, A Köttgen, M Elting…
JCI insight, 2018ncbi.nlm.nih.gov
Biallelic loss-of-function mutations in TRIP11, encoding the golgin GMAP-210, cause the
lethal human chondrodysplasia achondrogenesis 1A (ACG1A). We now find that a
homozygous splice-site mutation of the lamin B receptor (LBR) gene results in the same
phenotype. Intrigued by the genetic heterogeneity, we compared GMAP-210–and LBR-
deficient primary cells to unravel how particular mutations in LBR cause a phenocopy of
ACG1A. We could exclude a regulatory interaction between LBR and GMAP-210 in patients' …
Abstract
Biallelic loss-of-function mutations in TRIP11, encoding the golgin GMAP-210, cause the lethal human chondrodysplasia achondrogenesis 1A (ACG1A). We now find that a homozygous splice-site mutation of the lamin B receptor (LBR) gene results in the same phenotype. Intrigued by the genetic heterogeneity, we compared GMAP-210–and LBR-deficient primary cells to unravel how particular mutations in LBR cause a phenocopy of ACG1A. We could exclude a regulatory interaction between LBR and GMAP-210 in patients’ cells. However, we discovered a common disruption of Golgi apparatus architecture that was accompanied by decreased secretory trafficking in both cases. Deficiency of Golgi-dependent glycan processing indicated a similar downstream effect of the disease-causing mutations upon Golgi function. Unexpectedly, our results thus point to a common pathogenic mechanism in GMAP-210–and LBR-related diseases attributable to defective secretory trafficking at the Golgi apparatus.
ncbi.nlm.nih.gov